Literature DB >> 12370774

Progressive liver fibrosis in late-onset argininosuccinate lyase deficiency.

Toshihiko Mori1, Kazushige Nagai, Michio Mori, Masayoshi Nagao, Masakatsu Imamura, Mikio Iijima, Keiko Kobayashi.   

Abstract

A 4-month-old boy, with late-onset argininosuccinate lyase (ASL) deficiency with hepatomegaly, was treated by protein restricted diet and arginine supplementation; he was followed for 3 years. Hepatomegaly and mild liver dysfunction persisted without significant hyperammonemia. He maintained normal psychomotor development to the age of 12 months, but, at 3 years of age, his developmental status is in the borderline normal range. Liver biopsy performed at 12 months of age demonstrated swollen and pale hepatocytes with abnormal glycogen deposition and mild periportal fibrosis. A subsequent liver biopsy at 3 years of age showed progressive liver fibrosis in the periportal and central areas, which extended into the liver lobule. These findings suggest that liver impairment in ASL deficiency may advance without significant hyperammonemia and underline the importance of repeated liver biopsy in this disorder, even when the plasma ammonia level is well controlled.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12370774     DOI: 10.1007/s10024-002-0109-7

Source DB:  PubMed          Journal:  Pediatr Dev Pathol        ISSN: 1093-5266


  16 in total

1.  The phenotypic spectrum of organic acidurias and urea cycle disorders. Part 2: the evolving clinical phenotype.

Authors:  Stefan Kölker; Vassili Valayannopoulos; Alberto B Burlina; Jolanta Sykut-Cegielska; Frits A Wijburg; Elisa Leão Teles; Jiri Zeman; Carlo Dionisi-Vici; Ivo Barić; Daniela Karall; Jean-Baptiste Arnoux; Paula Avram; Matthias R Baumgartner; Javier Blasco-Alonso; S P Nikolas Boy; Marlene Bøgehus Rasmussen; Peter Burgard; Brigitte Chabrol; Anupam Chakrapani; Kimberly Chapman; Elisenda Cortès I Saladelafont; Maria L Couce; Linda de Meirleir; Dries Dobbelaere; Francesca Furlan; Florian Gleich; Maria Julieta González; Wanda Gradowska; Stephanie Grünewald; Tomas Honzik; Friederike Hörster; Hariklea Ioannou; Anil Jalan; Johannes Häberle; Gisela Haege; Eveline Langereis; Pascale de Lonlay; Diego Martinelli; Shirou Matsumoto; Chris Mühlhausen; Elaine Murphy; Hélène Ogier de Baulny; Carlos Ortez; Consuelo C Pedrón; Guillem Pintos-Morell; Luis Pena-Quintana; Danijela Petković Ramadža; Esmeralda Rodrigues; Sabine Scholl-Bürgi; Etienne Sokal; Marshall L Summar; Nicholas Thompson; Roshni Vara; Inmaculada Vives Pinera; John H Walter; Monique Williams; Allan M Lund; Angeles Garcia-Cazorla; Angeles Garcia Cazorla
Journal:  J Inherit Metab Dis       Date:  2015-04-15       Impact factor: 4.982

2.  Significant hepatic involvement in patients with ornithine transcarbamylase deficiency.

Authors:  Renata C Gallagher; Christina Lam; Derek Wong; Stephen Cederbaum; Ronald J Sokol
Journal:  J Pediatr       Date:  2014-01-30       Impact factor: 4.406

3.  Chronic liver disease and impaired hepatic glycogen metabolism in argininosuccinate lyase deficiency.

Authors:  Lindsay C Burrage; Simran Madan; Xiaohui Li; Saima Ali; Mahmoud Mohammad; Bridget M Stroup; Ming-Ming Jiang; Racel Cela; Terry Bertin; Zixue Jin; Jian Dai; Danielle Guffey; Milton Finegold; Sandesh Nagamani; Charles G Minard; Juan Marini; Prakash Masand; Deborah Schady; Benjamin L Shneider; Daniel H Leung; Deeksha Bali; Brendan Lee
Journal:  JCI Insight       Date:  2020-02-27

4.  Requirement of argininosuccinate lyase for systemic nitric oxide production.

Authors:  Ayelet Erez; Sandesh C S Nagamani; Oleg A Shchelochkov; Muralidhar H Premkumar; Philippe M Campeau; Yuqing Chen; Harsha K Garg; Li Li; Asad Mian; Terry K Bertin; Jennifer O Black; Heng Zeng; Yaoping Tang; Anilkumar K Reddy; Marshall Summar; William E O'Brien; David G Harrison; William E Mitch; Juan C Marini; Judy L Aschner; Nathan S Bryan; Brendan Lee
Journal:  Nat Med       Date:  2011-11-13       Impact factor: 53.440

5.  Nitric-oxide supplementation for treatment of long-term complications in argininosuccinic aciduria.

Authors:  Sandesh C S Nagamani; Philippe M Campeau; Oleg A Shchelochkov; Muralidhar H Premkumar; Kilian Guse; Nicola Brunetti-Pierri; Yuqing Chen; Qin Sun; Yaoping Tang; Donna Palmer; Anilkumar K Reddy; Li Li; Timothy C Slesnick; Daniel I Feig; Susan Caudle; David Harrison; Leonardo Salviati; Juan C Marini; Nathan S Bryan; Ayelet Erez; Brendan Lee
Journal:  Am J Hum Genet       Date:  2012-04-26       Impact factor: 11.025

6.  Unstable argininosuccinate lyase in variant forms of the urea cycle disorder argininosuccinic aciduria.

Authors:  Liyan Hu; Amit V Pandey; Cécile Balmer; Sandra Eggimann; Véronique Rüfenacht; Jean-Marc Nuoffer; Johannes Häberle
Journal:  J Inherit Metab Dis       Date:  2015-03-17       Impact factor: 4.982

7.  Systemic hypertension in two patients with ASL deficiency: a result of nitric oxide deficiency?

Authors:  Nicola Brunetti-Pierri; Ayelet Erez; Oleg Shchelochkov; William Craigen; Brendan Lee
Journal:  Mol Genet Metab       Date:  2009-06-13       Impact factor: 4.797

Review 8.  Optimizing therapy for argininosuccinic aciduria.

Authors:  Sandesh C S Nagamani; Brendan Lee; Ayelet Erez
Journal:  Mol Genet Metab       Date:  2012-07-20       Impact factor: 4.797

9.  A randomized controlled trial to evaluate the effects of high-dose versus low-dose of arginine therapy on hepatic function tests in argininosuccinic aciduria.

Authors:  Sandesh C S Nagamani; Oleg A Shchelochkov; Mary A Mullins; Susan Carter; Brendan C Lanpher; Qin Sun; Soledad Kleppe; Ayelet Erez; E O'Brian Smith; Juan C Marini; Brendan Lee
Journal:  Mol Genet Metab       Date:  2012-09-17       Impact factor: 4.797

10.  Low prevalence of argininosuccinate lyase deficiency among inherited urea cycle disorders in Korea.

Authors:  Dahye Kim; Jung Min Ko; Yoon-Myung Kim; Go Hun Seo; Gu-Hwan Kim; Beom Hee Lee; Han-Wook Yoo
Journal:  J Hum Genet       Date:  2018-05-17       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.